retatrutide peptide 20 mg Triple G (Retatrutyd) Retatrutide - Transforma Peptides

There is a suggestion from pooled data of increased rates of infections, specifically nasopharyngitis and urinary tract infections, which suggests a role for DPP-4 activity in normal immune surveillance, but whether this is clinically significant is still to be established

Always review the complete safety information that comes with your prescription and consult your prescriber with any questions

Kulas JA, Weigel TK, Ferris HA

doi: 10.1007/s00125-012-2459-7

The Phase 2 trial demonstrated that higher doses produce greater reductions in body weight, with the 12mg group achieving 24.2% average weight loss at 48 weeks